Taiwan Biotech Touts Drug Derived From Chinese Medicine To Treat Cancer Patients
This article was originally published in PharmAsia News
Executive Summary
Taiwan’s Maywufa Bio Pharmaceutical Group launched a cancer-related fatigue treatment derived from an herb used in traditional Chinese medicine and plans to investigate it for cardiovascular use with clinical trials in the United States.